A recent analysis from the large ADAPTABLE trial published in JAMA Cardiology showed that enteric coating on aspirin does not change effectiveness or safety for patients with cardiovascular disease.
An enteric coating did not hurt the effectiveness of aspirin pills for secondary prevention of atherosclerotic cardiovascular disease (ASCVD), but it didn't make it any safer either, researchers found ...
Please provide your email address to receive an email when new articles are posted on . Chewable aspirin showed lower venous thromboembolism rates after total knee arthroplasty vs. enteric-coated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results